Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 11/20 | 0.64 |
| ▸ | GCGR | P47871 | 1/20 | 0.64 |
| ▸ | GIPR | P48546 | 1/20 | 0.64 |
| ▸ | PTH1R | Q03431 | 1/20 | 0.63 |
| ▸ | ECE1 | P42892 | 1/20 | 0.62 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.62 |
| ▸ | VIPR2 | P41587 | 5/20 | 0.61 |
| ▸ | VIPR1 | P32241 | 3/20 | 0.61 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.59 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29880080 | 0.99 | PTH1R (0.64) | GLP1RGCGRGIPRPTH1RECE1 | |
| SCHEMBL30860116 | 0.97 | GLP1R (0.60) | GLP1RGCGRGIPRPTH1RECE1 | |
| SCHEMBL30860128 | 0.97 | GLP1R (0.60) | GLP1RGCGRGIPRPTH1RECE1 | |
| SCHEMBL31743242 | 0.96 | GLP1R (0.61) | GLP1RGCGRGIPRPTH1RECE1 | |
| SCHEMBL29770921 | 0.95 | VIPR2 (0.65) | GLP1RGCGRGIPRPTH1RECE1 | |
| SCHEMBL31065739 | 0.94 | GLP1R (0.61) | GLP1RGCGRGIPRPTH1RECE1 | |
| SCHEMBL30860112 | 0.94 | GLP1R (0.61) | GLP1RGCGRGIPRECE1MUS81 | |
| SCHEMBL29894848 | 0.94 | GLP1R (0.60) | GLP1RGCGRGIPRPTH1RECE1 | |
| SCHEMBL31009219 | 0.94 | GLP1R (0.61) | GLP1RGCGRGIPRPTH1RECE1 | |
| SCHEMBL31243561 | 0.93 | KEAP1 (0.67) | GLP1RGCGRGIPRPTH1RECE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023132609-A1 | LONG-ACTING FATTY ACID-PEPTIDE DERIVATIVE AND USE THEREOF | 주식회사 휴온스랩 | 2023-07-13 | — | — | WO | disclosed |